Your browser is no longer supported. Please, upgrade your browser.
GWPH GW Pharmaceuticals plc daily Stock Chart
GW Pharmaceuticals plc
Index- P/E- EPS (ttm)-9.60 Insider Own0.04% Shs Outstand27.31M Perf Week0.87%
Market Cap4.03B Forward P/E- EPS next Y-4.49 Insider Trans0.00% Shs Float1.68M Perf Month4.63%
Income-253.20M PEG- EPS next Q-2.51 Inst Own79.00% Short Float- Perf Quarter-0.95%
Sales16.80M P/S239.73 EPS this Y-84.20% Inst Trans0.12% Short Ratio- Perf Half Y10.56%
Book/sh18.75 P/B7.87 EPS next Y42.00% ROA-46.10% Target Price178.33 Perf Year32.56%
Cash/sh16.80 P/C8.78 EPS next 5Y- ROE-52.70% 52W Range101.07 - 179.65 Perf YTD11.71%
Dividend- P/FCF- EPS past 5Y- ROI-46.80% 52W High-17.91% Beta2.25
Dividend %- Quick Ratio11.20 Sales past 5Y-24.30% Gross Margin67.00% 52W Low45.91% ATR8.12
Employees586 Current Ratio11.30 Sales Q/Q50.00% Oper. Margin- RSI (14)47.34 Volatility4.53% 6.14%
OptionableYes Debt/Eq0.01 EPS Q/Q-63.70% Profit Margin- Rel Volume1.12 Prev Close143.23
ShortableYes LT Debt/Eq0.01 EarningsNov 06 AMC Payout- Avg Volume506.15K Price147.47
Recom2.10 SMA20-6.26% SMA500.58% SMA2006.71% Volume569,181 Change2.96%
Sep-28-18Reiterated BofA/Merrill Buy $181 → $197
Sep-07-18Resumed Morgan Stanley Overweight
Aug-15-18Initiated Stifel Buy $181
Aug-08-18Reiterated Cantor Fitzgerald Overweight $235 → $211
Apr-19-18Reiterated Cantor Fitzgerald Overweight $192 → $205
Feb-06-18Reiterated Cantor Fitzgerald Buy $208 → $192
Dec-14-17Upgrade Goldman Neutral → Buy
Oct-06-17Resumed Goldman Neutral
Aug-17-17Initiated Evercore ISI Outperform $154
Aug-08-17Downgrade Maxim Group Buy → Hold
Apr-21-17Initiated Maxim Group Buy $135
Dec-05-16Reiterated Cantor Fitzgerald Buy $182 → $208
Oct-07-16Initiated Goldman Buy
Oct-04-16Resumed Leerink Partners Outperform $162
Sep-26-16Reiterated Cantor Fitzgerald Buy $165 → $182
Aug-26-16Upgrade Numis Sell → Hold
Aug-09-16Reiterated Cantor Fitzgerald Buy $181 → $165
Jun-03-16Initiated Cantor Fitzgerald Buy $181
Mar-03-16Initiated Numis Sell
Feb-18-16Reiterated Leerink Partners Outperform $129 → $100
Oct-16-18 04:11PM  Marijuana stocks to watch: Meet the drugmaker making cannabis-based medicines for autism, cancer and more MarketWatch
03:47PM  The Most Unique Pot Stocks Investopedia
11:15AM  Marijuana Stocks to Watch in October -- and Into 2019 Motley Fool
Oct-15-18 06:03PM  Key event in the next month could take U.S. one step clos... CNBC Videos
03:30PM  5 Marijuana Stocks to Watch InvestorPlace
10:30AM  Why This Company is Set for a Major Breakout ACCESSWIRE
08:21AM  5 of the Most Unique Marijuana Stocks Motley Fool
08:00AM  Today's Research Reports on Trending Tickers: GW Pharmaceuticals and Aerie Pharmaceuticals ACCESSWIRE
Oct-12-18 12:45PM  How to Invest in Marijuana Stocks Motley Fool
Oct-10-18 08:49PM  How GW Pharmaceuticals is Changing the Cannabis Game in the U.S. Investopedia
10:30AM  Top Beverage Companies Entering CBD ACCESSWIRE
Oct-09-18 08:13AM  Marijuana ETFs: How to Find the Best Exchange-Traded Funds Motley Fool
Oct-07-18 06:31AM  Better Buy: GW Pharmaceuticals vs. Cara Therapeutics Motley Fool
Oct-06-18 08:03AM  Why GW Pharmaceuticals Stock Jumped 17.7% in September Motley Fool
Oct-05-18 06:22PM  Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week Benzinga
12:59PM  New Age Beverages Stock Bubbles Higher on Upcoming CBD Drinks Launch InvestorPlace
10:45AM  Cannabis Industry Service Provider Solving Major Challenges ACCESSWIRE
10:34AM  GW Pharmaceuticals plc Announces the Closing of Public Offering of ADSs, Raising Gross Proceeds of $345 Million and Full Exercise of Underwriters' Option to Purchase Additional ADSs GlobeNewswire
Oct-03-18 07:54AM  The Daily Biotech Pulse: Endologix's Q3 Sales, Obseva's Positive Trial Results, Kala To Offer Shares Benzinga
Oct-02-18 08:04PM  GW Pharmaceuticals plc Announces Pricing of Public Offering of ADSs Raising Gross Proceeds of $300 Million GlobeNewswire
10:30AM  DEA Rescheduling Makes CBD Stocks Blazing Hot ACCESSWIRE
09:10AM  The Daily Biotech Pulse: TransEnterix's Positive Pre-Announcement, Merit Medical Opens Wallet, GW Pharma To Offer ADS Shares Benzinga
08:21AM  Dow Jones Futures: Hot IPO Stitch Fix Dives, Marijuana Stocks India Global, New Age Beverages Swing Wildly Investor's Business Daily
Oct-01-18 04:29PM  Medical-marijuana company GW Pharma to sell $300 million in stock offering MarketWatch
04:01PM  GW Pharmaceuticals Announces Proposed Public Offering of ADSs GlobeNewswire
10:32AM  2 Marijuana Biotechs to Watch InvestorPlace
09:45AM  The Hottest CBD Stocks ACCESSWIRE
Sep-30-18 06:33AM  The Best-Performing Marijuana Stock of All Time (Hint: It's Probably Not Who You Think It Is) Motley Fool
Sep-29-18 11:41AM  Even if Sessions Is Fired, Marijuana Legalization Is a Long Shot Motley Fool
Sep-28-18 04:19PM  How Alexiam's Connor Is Trading GW Pharmaceuticals Bloomberg Video
04:19PM  How Alexiam's Connor Is Trading GW Pharmaceuticals Bloomberg
04:18PM  How Alexiam's Connor Is Trading GW Pharmaceuticals Bloomberg
02:39PM  Pot Stocks & ETF: Risks and Rewards Zacks
01:13PM  Take the Long View on Canopy Growths Potential InvestorPlace
09:40AM  3 Marijuana Stocks That Could Close Your Week With A Bang ACCESSWIRE
08:25AM  Todays Research Reports on Stocks to Watch: GW Pharmaceuticals and Tilray ACCESSWIRE
08:07AM  Some Cannabis Stocks Rise as DEA Rethinks CBD Stance
05:56AM  5 Most Popular Ways to Consume Cannabis Investopedia
Sep-27-18 08:31PM  Is This the Biggest Threat to GW Pharmaceuticals' Marijuana Drug? Motley Fool +6.98%
04:35PM  Why Marijuana Stocks GW Pharmaceuticals, Tilray, and Aleafia Health Jumped Today Motley Fool
03:15PM  Marijuana Stock GW Pharmaceuticals Nabs DEA Schedule V Motley Fool
02:39PM  GW Pharma stock jumps to record after DEA stance on its CBD drug, cannabis sector lags MarketWatch
01:33PM  The Midday Rundown: September 27th, 2018 CNBC Videos
01:30PM  First hard science on CBD: Why DEA just approved cannabis drug for kids with rare form of epilepsy CNBC
12:53PM  DEA permits GW Pharma to sell cannabis derived drug, CEO ... CNBC Videos
11:52AM  GW Pharmaceuticals Stock Surges on Epilepsy Drug News InvestorPlace
11:23AM  The pot stocks are soaring again after a CBD-based drug took a step closer to commercial launch CNBC
10:41AM  DEA reschedules Epidiolex, marijuana-derived drug, paving the way for it to hit the market CNBC
10:35AM  3 Marijuana Stocks Heading Higher In October 2018 ACCESSWIRE
09:27AM  GW Pharmaceuticals plc and its U.S. Subsidiary Greenwich Biosciences Announce the DEA has Rescheduled EPIDIOLEX® (cannabidiol) Oral Solution to Schedule V GlobeNewswire
08:51AM  The 10 Largest Marijuana Stocks Have Hit a Milestone Motley Fool
Sep-26-18 10:30AM  Medical Cannabis and Biotech Stocks to Watch ACCESSWIRE
08:21AM  5 Popular Marijuana Stocks That'll Lose Money in 2019 Motley Fool
Sep-25-18 01:12PM  CBD Doesn't Get You High, But Could Someday Eclipse the Entire Pot Industry
Sep-23-18 01:31PM  Better Buy: Insys Therapeutics, Inc. vs. GW Pharmaceuticals PLC Motley Fool
Sep-21-18 01:58PM  These three areas of the cannabis industry are really growing Yahoo Finance Video
07:30AM  Is Pot Stock GW Pharmaceuticals Undervalued? Motley Fool
Sep-20-18 03:35PM  Why GW Pharmaceuticals Stock Is Jumping Again Today Motley Fool +10.71%
Sep-19-18 04:31PM  Why GW Pharmaceuticals, Baidu, and W&T Offshore Jumped Today Motley Fool
03:35PM  GWPH Stock Surges on Reclassification of Epidiolex InvestorPlace
03:15PM  Cannabis a great global theme but valuations are ahead of... CNBC Videos
11:18AM  Marijuana Stocks Soar Again As Wall Street Eyes U.S. Imports Zacks
10:30AM  CBD Stocks Set to Explode ACCESSWIRE
09:16AM  Morgan Stanley: DEA Likely To Reclassify GW Pharma's Cannabinoid Therapy For US Launch Benzinga
08:46AM  GW Pharmaceuticals (GWPH) Catches Eye: Stock Jumps 5.9% Zacks
08:00AM  Today's Research Reports on Trending Tickers: GW Pharmaceuticals and Pfizer ACCESSWIRE
07:44AM  Pot stocks are soaring again with Tilray surging 50% in single day CNBC
Sep-18-18 01:35PM  Lacking quality weed extract, US researchers turn to Canada Associated Press +5.86%
09:29AM  Feds approve importation of pot drug for tremor study Associated Press
Sep-15-18 04:00PM  Should You Invest in Marijuana Stocks? Motley Fool
Sep-14-18 09:22AM  The Zacks Analyst Blog Highlights: Diageo, Constellation Brands, Cara, Cronos and GW Zacks
Sep-13-18 11:20PM  Massively Undervalued CBD Companies ACCESSWIRE
10:35AM  ETFs & Stocks to Tap Marijuana Boom Zacks
09:21AM  Investors in This Top Marijuana Stock Can't Overlook These 2 Serious Challenges Motley Fool
Sep-11-18 02:57PM  9 Marijuana Stocks to Play the Pot Craze InvestorPlace
07:51AM  4 Niche Marijuana Stocks With Massive Market Share Motley Fool
Sep-10-18 06:30AM  A Marijuana ETF Just Crossed $1B in Assets Investopedia
Sep-09-18 11:41AM  The U.S. Has a Marijuana Legalization Catch-22 on Its Hands Motley Fool
Sep-08-18 07:21AM  Midterm Elections Could Be a Turning Point for Marijuana Motley Fool
Sep-04-18 02:10PM  CBD Stocks Making Investors Big Profits ACCESSWIRE
Sep-02-18 11:41AM  3 Industries Looking to Partner With Marijuana Stocks Motley Fool
09:01AM  Is GW Pharmaceuticals PLC a Buy? Motley Fool
Sep-01-18 07:21AM  Nearly 37 Million Americans Used Marijuana in 2017 Motley Fool
Aug-31-18 03:36PM  9 High-Risk Stocks to Buy for Massive Rewards InvestorPlace
01:29PM  Do the Risks in Marijuana Stocks Outweigh the Rewards? InvestorPlace
Aug-29-18 04:13PM  How to Invest in Marijuana Stocks Motley Fool
Aug-28-18 09:20PM  Parsing Through CBD Companies, Focus on Revenue ACCESSWIRE
02:00AM  GW Pharmaceuticals presents latest cannabidiol oral solution (CBD) data at the 13th European Congress of Epileptology GlobeNewswire
Aug-26-18 10:05PM  [$$] GW Pharmaceuticals/cannabis: from dope to hope Financial Times
11:41AM  The 3 Biggest Hurdles to Legalizing Marijuana in the United States Motley Fool
09:33AM  2 Blockbuster New Drug Launches Making Investors Nervous Right Now Motley Fool
Aug-25-18 07:21AM  A Record Number of Americans Support Legalizing Marijuana, New Survey Shows Motley Fool
Aug-22-18 11:30AM  Sticker Shock: Is GW Pharmaceutical's Epidiolex Really That Expensive? Benzinga
10:30AM  CBD Making Investors Boatloads ACCESSWIRE
08:47AM  Everything You Need To Know From The Cannabis Capital Conference Benzinga
Aug-21-18 03:26PM  The Amazon of Cannabis Investopedia
02:12PM  Why the Cannabis Market (And These Cannabis Stocks) Could Be Huge InvestorPlace
12:20PM  Edited Transcript of GWPH.O earnings conference call or presentation 7-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-19-18 11:41AM  Don't Fall Over, but the DEA Just Changed Its Tune on Marijuana Motley Fool
Aug-17-18 08:21AM  5 Marijuana Stocks With the Highest Expected Sales Next Year Motley Fool
GW Pharmaceuticals plc, a biopharmaceutical company, engages in discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. The company operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. Its lead product is Epidiolex, an oral medicine which is in Phase III clinical development for the treatment of refractory childhood epilepsies, as well as for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, and infantile spasms. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates, which are in Phase I and II clinical development for the treatment of glioma, neonatal hypoxic-ischemic encephalopathy, adult epilepsy, and schizophrenia. Further, the company has license and development agreements with Otsuka Pharmaceutical Co. Ltd.; Almirall S.A.; Bayer HealthCare AG; Ipsen Biopharm Ltd; and Neopharm Group. It primarily operates in Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.